{"id":322027,"date":"2020-08-18T10:00:00","date_gmt":"2020-08-18T08:00:00","guid":{"rendered":"https:\/\/medizinonline.com\/von-willebrand-syndrome-with-impressive-bleeding-history\/"},"modified":"2020-08-18T10:00:00","modified_gmt":"2020-08-18T08:00:00","slug":"von-willebrand-syndrome-with-impressive-bleeding-history","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/en\/von-willebrand-syndrome-with-impressive-bleeding-history\/","title":{"rendered":"Von Willebrand syndrome with impressive bleeding history"},"content":{"rendered":"<p><strong>A patient who had already suffered four miscarriages related to bleeding complications presents for thrombophilia screening at the 6th week of gestation. During the diagnostic process, Von Willebrand syndrome is detected, which must be taken into account in the course of pregnancy, during delivery and in the puerperium.<\/strong><\/p>\n<p><!--more--><\/p>\n<p><img fetchpriority=\"high\" decoding=\"async\" class=\" size-full wp-image-13894\" style=\"height: 603px; width: 600px;\" src=\"https:\/\/medizinonline.com\/wp-content\/uploads\/2020\/08\/fall3_0.png\" alt=\"\" width=\"1100\" height=\"1105\" srcset=\"https:\/\/medizinonline.com\/wp-content\/uploads\/2020\/08\/fall3_0.png 1100w, https:\/\/medizinonline.com\/wp-content\/uploads\/2020\/08\/fall3_0-800x804.png 800w, https:\/\/medizinonline.com\/wp-content\/uploads\/2020\/08\/fall3_0-80x80.png 80w, https:\/\/medizinonline.com\/wp-content\/uploads\/2020\/08\/fall3_0-120x120.png 120w, https:\/\/medizinonline.com\/wp-content\/uploads\/2020\/08\/fall3_0-90x90.png 90w, https:\/\/medizinonline.com\/wp-content\/uploads\/2020\/08\/fall3_0-320x320.png 320w, https:\/\/medizinonline.com\/wp-content\/uploads\/2020\/08\/fall3_0-560x563.png 560w\" sizes=\"(max-width: 1100px) 100vw, 1100px\" \/><\/p>\n<table style=\"width: 508px;\" border=\"1\" cellspacing=\"0\" cellpadding=\"0\">\n<tbody>\n<tr>\n<td style=\"width: 161px;\">\n<div><strong>Laboratory values<\/strong><\/div>\n<\/td>\n<td style=\"width: 116px;\">\n<div><strong>Baseline<\/strong><\/div>\n<div>(10.12.2018)<\/div>\n<\/td>\n<td style=\"width: 116px;\">\n<div><strong>23. SSW<\/strong><\/div>\n<div>(20.03.2019)<\/div>\n<\/td>\n<td style=\"width: 116px;\">\n<div><strong>29TH SSW<\/strong><\/div>\n<div>(06.05.2019)<\/div>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 161px;\">\n<div>aPTT<\/div>\n<\/td>\n<td style=\"width: 116px;\">\n<div>26s<\/div>\n<\/td>\n<td style=\"width: 116px;\">\n<div>25s<\/div>\n<\/td>\n<td style=\"width: 116px;\">\n<div>24s<\/div>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 161px;\">\n<div>FVIII:C<\/div>\n<\/td>\n<td style=\"width: 116px;\">\n<div>123%<\/div>\n<\/td>\n<td style=\"width: 116px;\">\n<div><strong>231%<\/strong><\/div>\n<\/td>\n<td style=\"width: 116px;\">\n<div><strong>238%<\/strong><\/div>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 161px;\">\n<div>VWF:Ag<\/div>\n<\/td>\n<td style=\"width: 116px;\">\n<div>106.0%<\/div>\n<\/td>\n<td style=\"width: 116px;\">\n<div><strong>185.5%<\/strong><\/div>\n<\/td>\n<td style=\"width: 116px;\">\n<div><strong>196.8%<\/strong><\/div>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 161px;\">\n<div>VWF:RCo<\/div>\n<\/td>\n<td style=\"width: 116px;\">\n<div><strong>49.1%<\/strong><\/div>\n<\/td>\n<td style=\"width: 116px;\">\n<div><strong>52.8%<\/strong><\/div>\n<\/td>\n<td style=\"width: 116px;\">\n<div><strong>60.9%<\/strong><\/div>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 161px;\">\n<div>VWF:CBA<\/div>\n<\/td>\n<td style=\"width: 116px;\">\n<div><strong>46.0%<\/strong><\/div>\n<\/td>\n<td style=\"width: 116px;\">\n<div>53.2%<\/div>\n<\/td>\n<td style=\"width: 116px;\">\n<div>63.7%<\/div>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 161px;\">\n<div>VWF:RCo\/VWF:Ag Ratio<\/div>\n<\/td>\n<td style=\"width: 116px;\">\n<div><strong>0.5<\/strong><\/div>\n<\/td>\n<td style=\"width: 116px;\">\n<div><strong>0.3<\/strong><\/div>\n<\/td>\n<td style=\"width: 116px;\">\n<div><strong>0.3<\/strong><\/div>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 161px;\">\n<div>Protein S activity<\/div>\n<\/td>\n<td style=\"width: 116px;\">\n<div>N\/A<\/div>\n<\/td>\n<td style=\"width: 116px;\">\n<div><strong>45.3%<\/strong><\/div>\n<\/td>\n<td style=\"width: 116px;\">\n<div>N\/A<\/div>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 161px;\">\n<div>Free protein S<\/div>\n<\/td>\n<td style=\"width: 116px;\">\n<div>N\/A<\/div>\n<\/td>\n<td style=\"width: 116px;\">\n<div><strong>51.9%<\/strong><\/div>\n<\/td>\n<td style=\"width: 116px;\">\n<div>N\/A<\/div>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 161px;\">\n<div>D-dimers<\/div>\n<\/td>\n<td style=\"width: 116px;\">\n<div>N\/A<\/div>\n<\/td>\n<td style=\"width: 116px;\">\n<div><strong>2.27 mg\/L<\/strong><\/div>\n<\/td>\n<td style=\"width: 116px;\">\n<div><strong>2.67 mg\/L<\/strong><\/div>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 161px;\">\n<div>PFA-100<\/div>\n<\/td>\n<td style=\"width: 116px;\">\n<div><strong>231s\/147s<\/strong><\/div>\n<\/td>\n<td style=\"width: 116px;\">\n<div><strong>167s\/110s<\/strong><\/div>\n<\/td>\n<td style=\"width: 116px;\">\n<div>N\/A<\/div>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<div><\/div>\n<div><span style=\"font-size: 11px;\">An overview with gestational age-specific reference intervals can be found in<\/span><\/div>\n<div><span style=\"font-size: 11px;\">Szecsi PB et al: Haemostatic reference intervals in pregnancy.&nbsp;Thromb Haemost. 2010;103(4):718-727.<\/span><\/div>\n<table style=\"width: 588px;\" border=\"1\" cellspacing=\"1\" cellpadding=\"3\">\n<tbody>\n<tr>\n<td style=\"width: 574px;\"><strong>Comment by Rosa Sonja Alesci, MD<\/strong><\/p>\n<p><img decoding=\"async\" style=\"float: left; height: 150px; width: 156px;\" data-src=\"https:\/\/assets.medizinonline.com\/sites\/default\/files\/field\/images\/1drmedrosasonjaalesci.png\" alt=\"\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" class=\"lazyload\">Von Willebrand syndrome is significantly underdiagnosed overall, as this case of a 33-year-old female patient also shows. Many sufferers have become accustomed to the symptoms and do not see a doctor. Thus, during thrombophilia screening in the context of habitual abortions, it is not uncommon for Von Willebrand syndrome to be diagnosed as an incidental finding. In the present case, especially in view of the four previous miscarriages with hemorrhage and the very impressive bleeding history, replacement of Von Willebrand factor during pregnancy was essential. In addition, the patient had to be closely monitored, especially at the beginning, since&nbsp;was also known to have thrombophilia. This made it possible to respond to individual circumstances and to react quickly to conspicuous complications. Overall, the present case demonstrates that recombinant Von Willebrand factor (Veyvondi\u00ae) can be successfully used in a rare type of Von Willebrand syndrome. After a history of four miscarriages, the vaginal bleeding during pregnancy was optimally treated and the birth was also without complications. No thrombotic side effects occurred and Veyvondi\u00ae could also be administered without problems in the puerperium.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><img decoding=\"async\" class=\"image-article-default-image lazyload\" style=\"height: 234px; width: 600px;\" data-src=\"https:\/\/assets.medizinonline.com\/sites\/default\/files\/field\/images\/berechnung_1357.png\" alt=\"\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\"><\/p>\n<p><span style=\"font-size: 10px;\">See also current technical information VEYVONDI<\/span><sup>\u00ae<\/sup><span style=\"font-size: 10px;\">&nbsp;<\/span><a style=\"font-size: 10px;\" href=\"http:\/\/www.swissmedicinfo.ch\" target=\"_blank\" rel=\"noopener\">www.swissmedicinfo.ch<\/a><\/p>\n<p><strong><span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">Abbreviations<\/span><\/strong><\/p>\n<p><span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">aPTT = activated partial thromboplastin time; FVIII:C = factor VIII activity; GI = gastrointestinal; IU = international unit; PFA-100 = Platelet Function Analyzer 100; VWF:Ag = von Willebrand factor antigen; VWF:CBA = von Willebrand factor collagen binding activity; VWF:RCo = von Willebrand factor ristocetin cofactor activity; CNS = central nervous system.<\/span><\/p>\n<p><img decoding=\"async\" class=\"size-full wp-image-13895 lazyload\" style=\"--smush-placeholder-width: 1100px; --smush-placeholder-aspect-ratio: 1100\/368;height: 67px; width: 200px;\" data-src=\"https:\/\/medizinonline.com\/wp-content\/uploads\/2020\/08\/takeda_logo_rgb.png\" alt=\"\" width=\"1100\" height=\"368\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\"><\/p>\n<p><span style=\"font-size: 11px;\">C-APROM\/CH\/\/0782 &nbsp;07\/2020&nbsp;<\/span><\/p>\n<p><strong><br \/>\n  <span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">VEYVONDI<\/span><br \/>\n<\/strong><strong><br \/>\n  <span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\"><sup>\u00ae<\/sup> <\/span><br \/>\n<\/strong><strong><br \/>\n  <span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">Brief technical information<\/span><br \/>\n<\/strong><\/p>\n<p><strong><span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">Z:  <\/span><\/strong><span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">Active ingredient: Vonicogum alfa.  <\/span><strong><span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">I:  <\/span><\/strong><span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">Treatment of hemorrhage or bleeding due to surgery in the from<\/span><span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">&#8211;<\/span><span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">Willebrand<\/span><span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">&#8211;<\/span><span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">disease when therapy with desmopressin (DDAVP) alone is ineffective or contraindicated.  <\/span><strong><span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">D:  <\/span><\/strong><span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">Dosage and frequency must be individualized based on clinical judgment and based on patient weight, type and severity of bleeding episodes\/surgical intervention, and based on monitoring of appropriate clinical and laboratory measurements; Intravenous administration.  <\/span><strong><span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">AI:  <\/span><\/strong><span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">Hypersensitivity to the active substance or any of the excipients. Known allergic reaction to mouse<\/span><span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">&#8211; <\/span><span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">or hamster proteins. <\/span><strong><br \/>\n  <span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">VM: <\/span><br \/>\n<\/strong><span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">There are hypersensitivity<\/span><span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">&#8211; <\/span> <span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">or allergic reactions occurred, which may progress to severe anaphylaxis. Monitor patients closely during infusion. Neutralizing antibodies can be formed against Von<\/span><span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">&#8211;<\/span><span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">Willebrand<\/span><span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">&#8211;<\/span><span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">Develop factor. There is a risk of thrombotic events.  <\/span><strong><span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">SS:  <\/span><\/strong><span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">Use only with clear indication.  <\/span><strong><span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">UW:  <\/span><\/strong><span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">From<\/span><span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">&#8211;<\/span><span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">Willebrand<\/span><span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">&#8211;<\/span><span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">Factor Inhibitors, Hypersensitivity<\/span><span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">&#8211;  <\/span><span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">or allergic reactions, tremor, hypertension, vertigo, deep vein thrombosis, ECG changes.  <\/span><strong><span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">IA:  <\/span><\/strong><span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">There are no known interactions.  <\/span><strong><span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">P:  <\/span><\/strong><span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">Lyophilisate with 650 I.U. or 1,300 I.U. with 5 ml (resp. 10 ml for 1,300 I.E.) water for injection. Levy category B.  <\/span><strong><span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">Z:  <\/span><\/strong><span style=\"font-family: ubuntu,sans-serif; font-size: 8pt;\">Takeda Pharma AG, 8152 Opfikon. You can find detailed information at  <\/span><span style=\"color: #954f72; font-family: ubuntu,sans-serif; font-size: 8pt;\"><a style=\"color: #954f72;\" href=\"http:\/\/www.swissmedicinfo.ch\" target=\"_blank\" rel=\"noopener\">www.swissmedicinfo.ch<\/a><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A patient who had already suffered four miscarriages related to bleeding complications presents for thrombophilia screening at the 6th week of gestation. During the diagnostic process, Von Willebrand syndrome is&hellip;<\/p>\n","protected":false},"author":7,"featured_media":96996,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Case report: Pregnancy and birth","footnotes":""},"category":[11520,11508,11400,11353,11548],"tags":[11734,11733],"powerkit_post_featured":[],"class_list":["post-322027","post","type-post","status-publish","format-standard","has-post-thumbnail","category-cases-en","category-education","category-gynecology","category-hematology","category-rx-en","tag-veyvondi-en","tag-willebrand-syndrome","pmpro-has-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-05-06 12:43:31","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":14439,"slug":"la-maladie-de-von-willebrand-avec-un-contexte-hemorragique-complexe","post_title":"La maladie de von Willebrand avec un contexte h\u00e9morragique complexe","href":"https:\/\/medizinonline.com\/fr\/la-maladie-de-von-willebrand-avec-un-contexte-hemorragique-complexe\/"},"it_IT":{"locale":"it_IT","id":322029,"slug":"sindrome-di-von-willebrand-con-unimpressionante-storia-di-emorragia","post_title":"Sindrome di Von Willebrand con un'impressionante storia di emorragia.","href":"https:\/\/medizinonline.com\/it\/sindrome-di-von-willebrand-con-unimpressionante-storia-di-emorragia\/"},"pt_PT":{"locale":"pt_PT","id":322030,"slug":"sindrome-de-von-willebrand-com-uma-impressionante-historia-de-hemorragia","post_title":"S\u00edndrome de Von Willebrand com uma impressionante hist\u00f3ria de hemorragia","href":"https:\/\/medizinonline.com\/pt-pt\/sindrome-de-von-willebrand-com-uma-impressionante-historia-de-hemorragia\/"},"es_ES":{"locale":"es_ES","id":322028,"slug":"sindrome-de-von-willebrand-con-antecedentes-hemorragicos-impresionantes","post_title":"S\u00edndrome de von Willebrand con antecedentes hemorr\u00e1gicos impresionantes","href":"https:\/\/medizinonline.com\/es\/sindrome-de-von-willebrand-con-antecedentes-hemorragicos-impresionantes\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/322027","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/comments?post=322027"}],"version-history":[{"count":2,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/322027\/revisions"}],"predecessor-version":[{"id":323256,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/322027\/revisions\/323256"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media\/96996"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media?parent=322027"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/category?post=322027"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/tags?post=322027"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/powerkit_post_featured?post=322027"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}